Abstract:Background: Transmission-based precautions against varicella-zoster virus (VZV) in healthcare settings are determined by the extent of rash (localized vs disseminated) and the immune status of the host. At our facility, immunocompetent patients with localized disease are placed in standard precautions whereas patients with disseminated disease and/or immunocompromised status are placed in airborne and contact isolation. The use of molecular diagnostics has increased recently, and patients can have a PCR positive for VZV in cerebral spinal fluid (CSF) without evidence of pneumonia or disseminated rash. These patients are classified as disseminated disease, but it is unlikely that they are spreading VZV via respiratory aerosols in the absence of other symptoms. Infection prevention guidance is limited in this situation, and these patients may be in unneeded isolation, with the potential for adverse patient effects and overutilizing PPE resources. We have described the clinical characteristics of patients with a PCR positive for VZV in CSF, and we evaluated the risk for transmitting VZV via airborne aerosols. Methods: A retrospective, single-center chart review was performed on all patients admitted with a PCR positive for VZV in CSF between July 2017 and November 2021. Chart review was performed to gather data regarding clinical presentation, patient characteristics, and risk factors. Results: In total, 38 patients were identified who had a PCR positive for VZV in CSF; 22 (57.9%) were male and 16 (42.1%) were female. The median age was 47 years (IQR, 38–69). Also, 15 patients (39.5%) were immunocompromised. Moreover, 26 patients (68.4%) had a rash; 19 (50%) had localized rash; and 7 (18.4%) had disseminated rash involving ≥3 dermatomes. However, 12 patients (31.5%) had neither rash nor pneumonia. Furthermore, 5 patients (13.1%) had PCR positive for VZV in CSF and developed rash within the following 2–7 days (2 with disseminated rash). In addition, 6 patients (15.8%) had pneumonia. Of the 6 patients with pneumonia, 4 (10.5%) were immunocompromised and 3 (7.9%) were above 65-year-old. 32 patients (84.2%) were kept in airborne and contact precautions. 1 (2.6%) patient had a documented record of at least 1 dose of Shingrix vaccine. Conclusions: Most patients with a PCR test positive for VZV in the CSF were not immunocompromised and did not have evidence of disseminated rash or pneumonia. The risk of airborne transmission of VZV via small aerosols appears to be low in patients with a PCR test positive for VZV in the CSF without evidence of disseminated rash or pneumonia. Airborne isolation may not be required for many of these patients. Funding: None Disclosures: None

Varicella pneumonia in a healthy 31-year-old female with no prior varicella immunity and no skin rush: A case report

Varicella Pneumonia in Immunocompetent Adults: Symptomatic and Asymptomatic Cases

Prevalence and progression of pneumonia in immunocompetent adults with varicella

Disseminated Varicella-Zoster Virus Presenting With Pneumonitis and Diffuse Alveolar Hemorrhage in an Immunocompetent Patient

Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review.

Clinical and radiological features of a cluster of immunocompetent adolescents with varicella pneumonia: a descriptive study

Acute Pancreatitis Associated with Herpes Zoster: Case Report and Literature Review.

Case Report: Neonatal Varicella Acquired From Maternal Zoster

Concurrence of Chicken Pox and Varicella Zoster Virus Encephalitis in an Immunocompetent Female: A Case Report

Clinical Profile of Hospitalized Varicella Cases From Pediatric Emergency Consultations: A Retrospective Cohort Study

Atypical presentation of varicella-zoster virus reactivation in a lung transplant patient: a case report

Challenges in Diagnosing Varicella-Zoster Virus Encephalitis in an Immunocompromised Patient

Fatal varicella due to the vaccine-strain varicella-zoster virus

Association between emphysema and other pulmonary computed tomography patterns in primary varicella pneumonia: A retrospective cohort study

Chickenpox: presentation and complications in adults

Varicella zoster virus outbreak in a long-term care unit of a tertiary care hospital in northern India

Varicella-zoster virus post-exposure management and prophylaxis: A review

Zoster on the brain: Clinical characteristics of patients PCR positive for varicella-zoster virus in cerebrospinal fluid and implications for transmission base

Fatal Disseminated Varicella-Zoster Virus in an Immunocompetent Woman

Cerebral Venous Thrombosis and Acute Pulmonary Embolism following Varicella Infection

Progress in the treatment and prevention of varicella